Fermion
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
Something doesn't seem right in your math. $52 -> $185 = 3.5x increase. How do you get $10K -> $100K, a 10x increase?
Didn't Nflx split?
Something doesn't seem right in your math. $52 -> $185 = 3.5x increase. How do you get $10K -> $100K, a 10x increase?
Can you buy sell buy sell etc on same day with the same money? Or does the trade have to settle over a few days?
I have not researched this stock at all but the volatility described and volume for a small stock sounds like a pump and dump scheme. Two of my coworkers got caught up in these. They made money on the first one and lost everything, including the original money put in and a second deposit trying to double down when the next three stocks dropped in just a few minutes before they could get out. They lost $20,000 each they couldn't afford to lose and are still on the email and mailing lists of every boiler room out there.
It could be a major winner but I'd treat it as money spent the minute I hit the buy button.
Not sure if you are courageous or on a gambling high there, Fermion.
But a fun ride regardless, thanks for sharing!
I have this on a post it note when my finger hovers on the sell button:
"Pharmacyclics’ little-known chemical, now a drug called Imbruvica, sent company shares soaring from $2 to $261.25 in one of the largest acquisitions in Silicon Valley"
You should also have a post it with the hot tech stocks from 2000 that went to a million and then zero .
EToys was a winner for me. Not because I invested in the stock (peak of $84/share) but because I bought a load of their inventory and sold it on Ebay. My basement was full of various toys, I did a quick turnover with a pretty nice return.I can do one better. I have a stuffed animal on my desk from Etoys (bought it in the bankruptcy sales for like $0.25 along with some Kinect toys)
Shares of Endocyte have quadrupled since the company announced a prostate-specific membrane antigen licensing deal on Monday, STAT's Adam Feuerstein writes in a story titled "How a whole lot of hype sent Endocyte's stock soaring for no good reason." A "seasoned biotech business development executive" told the journalist that "PSMA is a target proven over and over as ineffective in treating prostate cancer due to significant off-target toxicity."
Beats me.
On Tuesday, after you started this thread, I saw a blurb on the Web about a bitty company called Celsion seeing its shares jump from $1.50 to close at $6. Now, two days later, it settles down to $3.60. Out of curiosity, I looked at the news, and it appeared they had some good news on a trial of their ovarian cancer drug on 14 patients.
Never heard of this company, so I looked back at its stock history, and found that it traded as low as $0.25 a few months ago. Look further out to 1999, the stock started to trade at $50, then climbed as high as $540 in the tech stock mania of 2000. Almost twenty years, and they have not gotten a drug yet.
Boy, way too volatile for my taste. Hence, I only do big names or ETFs when it comes to biotech.
The worst would be a buyout at like $15 a share. We would have to recognize several hundred thousand in short term capital gains plus pay back ACA subsidy for this entire year. Combined those would be around $100,000 in taxes on a $220,000 gain. We have like no deductions.
Better scenario is a slow walk to $15 or $30 by the drug launch in 2021. I can then sell 1000 shares a year for the next decade and use the money as MAGI for ACA.
Imagine financing your whole retirement on one $50,000 purchase of stock...
Never heard of this company, so I looked back at its stock history, and found that it traded as low as $0.25 a few months ago. Look further out to 1999, the stock started to trade at $50, then climbed as high as $540 in the tech stock mania of 2000. Almost twenty years, and they have not gotten a drug yet.
Boy, way too volatile for my taste. Hence, I only do big names or ETFs when it comes to biotech.